Clínica Adventista Belgrano - CABA - Buenos Aires
Clínica Adventista Belgrano. Contamos con basta experiencia en el Area de investigación Clínica. Desde el inicio y hasta la actualidad hemos participado en Innumerables estudios clínicos de distintas áreas habiendo desarrollado múltiples programa de investigación. En definitiva nos hemos convertido en una institución de prestigio por la calidad de atención y el nivel técnico científico .Estomba 1710, CABA, Buenos Aires
Select an option
I am a doctor
I am a sponsor
Specializations
Covid-19
Coronavirus
Cáncer de mama
Cáncer de pulmón
Lupus eritematoso sistémico
Taquicardia supraventricular paroxística
Melanoma
Enfermedad de Crohn
Lupus eritematoso sistémico
Artroplastia
Reemplazo de rodilla
Artritis reumatoide
Obesidad
Colitis ulcerosa
Our team
Medical staff
Guido Garozzo
Federico Javier Ariel
Marcelo Martin Casas
Aldo Perfetti
Gabriela Goncalvez
Lorena Osorio
Fernando Cid
Lucía Beloqui
Daiana Melisa Troncoso
Carolina Aimo
Nicolas Cazap
Camila Montalvo
Open studies
Lung cancer
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer - GlaxoSmithKlineSee more
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation - Krascendo 170 - Hoffmann-La RocheSee more
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - INTerpath-002 - Merck Sharp & Dohme LLCSee more
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) and Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009) - Merck Sharp & Dohme LLCSee more
Skin cancer
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma - Regeneron PharmaceuticalsSee more
A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) - V940-001 - Merck Sharp & Dohme LLCSee more
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02) - MK-3475-02B - Merck Sharp & Dohme LLCSee more
Lupus
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus - APATURA - SanofiSee more
A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy - AMETHYST - BiogenSee more
Advanced tumors
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) - HAMMER - Synthorx, Inc, a Sanofi companySee more
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Chronic bronchitis
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
Chronic obstructive pulmonary disease
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) - PILASTER - Chiesi Farmaceutici S.p.A.See more
Multiple myeloma
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM - IRAKLIA - SanofiSee more
Non-Hodgkin Lymphoma
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - LOTIS 5 - ADC Therapeutics S.A.See more
Pneumonia
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) - ESsCAPE - BiotestSee more
Solid tumors
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) - HAMMER - Synthorx, Inc, a Sanofi companySee more
